karen c. weber
Federal University of ParaĂba
JoĂŁo Pessoa, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
Federal University of ParaĂba
JoĂŁo Pessoa, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Anti-Cancer Drugs
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
Nanyang Technological University
Singapore, Singapore
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
Jiangsu Kanion Pharmaceutical Co., Ltd.
Lianyungang, China
Review Editor
Cardiovascular and Hematologic Drugs
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Anti-Cancer Drugs
Tsinghua University
Beijing, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Sun Yat-sen University
Guangzhou, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
School of Pharmacy, Anhui Medical University
Hefei, China
Review Editor
Anti-inflammatory and Immunomodulating Agents
University of Florida
Gainesville, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Arkansas at Little Rock
Little Rock, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (CAS)
Guangzhou, China
Review Editor
Anti-Cancer Drugs
Boston University
Boston, United States
Review Editor
Anti-Infective Agents
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
King's College London
London, United Kingdom
Review Editor
Technologies and Strategies to Enable Drug Discovery